Resources

This infographic provides a quick view of the coronavirus (COVID-19) situation in Australia on 2 September 2022.

Health Ministers met on 2 September 2022 and discussed concerns regarding cosmetic surgery, especially the risks to consumers.

This presentation, delivered on 5 September 2022, contains an update to Australia's COVID-19 vaccine rollout.

This data file contains statistical data about Australia's COVID-19 vaccinations.

These reports list the percentage of people who have been vaccinated against COVID-19 by local government area (LGA).

This document summarises the discussion and outcomes of the first Digital Transformation Sector Partners meeting on 2 September 2022.

This infographic provides a quick view of the coronavirus (COVID-19) situation in Australia on 1 September 2022.

This presentation, delivered on 2 September 2022, contains an update to Australia's COVID-19 vaccine rollout.

This data file contains statistical data about Australia's COVID-19 vaccinations.

This weekly report provides a snapshot of data on the impact of COVID-19 in residential aged care facilities nationally. The report includes data on the number of services impacted and number of staff and resident cases, as well as workforce, testing and PPE provided to affected services.

This declaration from the Minister for Health and Aged Care is a reporting requirement under Section 34A of the Tobacco Advertising Prohibition Act 1992.

This infographic provides a quick view of the coronavirus (COVID-19) situation in Australia on 31 August 2022.

This presentation, delivered on 1 September 2022, contains an update to Australia's COVID-19 vaccine rollout.

This data file contains statistical data about Australia's COVID-19 vaccinations.

Summary of the consideration of the application from Sanofi Pty Ltd for the inclusion of avalglucosidase alfa (Nexviazyme®) on the Life Saving Drugs Program (LSDP) for the treatment of Pompe Disease.

This report outlines the Elosulfase alfa 24 Month Review Terms of Reference and Protocol Questions

Facilities that handle security sensitive biological agents (SSBAs) can use this template to help them make sure they identify and manage all risks associated with handing SSBAs. Use of the template is not mandatory.

This tool helps entities and facilities that handle security sensitive biological agents (SSBAs) to check their compliance with the SSBA Standards. Use of this tool is not mandatory.

This report sets out the number of refusals by insurers to provide insurance cover to medical practitioners and the number of contracts with a risk surcharge in 2021–22. It also sets out the total number of withdrawals from contracts, and complaints about refusals and surcharges.

Use this form to apply for access to our documents under the Freedom of Information Act 1982 (FOI Act).

This consultation paper was intended to solicit information for the development and implementation of reforms to private health insurance.

This document summarises the key findings of a scoping study on multidisciplinary care in residential aged care homes, and a proposed model of care.

Our Corporate Plan outlines how we will deliver the health system for all Australians throughout 2022–23.

This infographic provides a quick view of the coronavirus (COVID-19) situation in Australia on 30 August 2022.

This presentation, delivered on 31 August 2022, contains an update to Australia's COVID-19 vaccine rollout.